Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1976-10-18
1978-06-20
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260558A, 260558S, A61K 31165, C07C10320
Patent
active
040962776
ABSTRACT:
A mucolytic process is disclosed which comprises contacting N-(2-hydroxyethyl)mercaptoacetamidobenzamides or mercaptoacylamidobenzoic acids, mercaptoacetylsulfanilic acids and alkanoylthio derivatives thereof with mucus. Illustrative of compounds useful in the mucolytic process of the present invention are 4-(2-mercaptoacetamido)-benzoic acid and N-(2-mercaptoacetyl)sulfanilic acid.
REFERENCES:
patent: 2448939 (1948-09-01), Weissberger et al.
patent: 2520293 (1950-08-01), Weiss
patent: 2607789 (1952-08-01), Weiss
patent: 3091569 (1963-05-01), Scheffner
patent: 3663690 (1972-05-01), Eichel
patent: 3770824 (1973-11-01), Phillips
patent: 3809697 (1971-10-01), Martin et al.
Scheffner, Ann. New York Acad. Sci. 106, 298-310 (1963).
W. S. Poonia et al., Indian J. Applied Chem., vol. 27(1) 32-33 (1964).
Comer William Timmey
Martin Tellis Alexander
Carnahan Robert E.
Mead Johnson & Company
Schenkman Leonard
Uloth Robert H.
LandOfFree
Mucolytic mercaptoacylamidobenzamides and process of using same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mucolytic mercaptoacylamidobenzamides and process of using same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mucolytic mercaptoacylamidobenzamides and process of using same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1134917